“…By comprehensively considering the network-based predicted ranking, chemical structure, physicochemical properties, availability, and accessibility, these promising ingredients were selected for antistroke efficacy evaluation ( Figure 5 ). Subsequently, the OGD/R injury model, a recognized in vitro model in ischemic stroke research, was applied for pharmacological validation [ 46 , 47 ]. As shown in Figure 6 , the OGD/R insult group showed significantly lowered PC12 cell viability ( P < 0.01), while CA (6.25, 12.5, and 25 μ M), SCU (1, 2, and 4 μ M), chrisin (1, 2, and 4 μ M), fisetin (12 μ M), gallic acid (6.25 μ M), imperatorin (1, 2, and 4 μ M), and palmatine (3.125, 6.25, and 12.5 μ M) increased the viability of PC12 cells ( ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001, respectively).…”